InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the detailed record of transactions filed by LaPlume Joseph W, Vice-Président Exécutif. Officer active across 2 companies, notably Charles River Laboratories International, INC.. Cumulatively, 11 disclosures have been logged. Total volume traded: €1.1m. The latest transaction was disclosed on 27 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
01,657 shares0
Common Stock
SEC:0001127602-22-016066:0·
€102,070395 shares@ €258.40460.0014% mcap9.4% of flow
Common Stock
SEC:0001127602-22-006657:0·
0150 shares0
Common Stock
SEC:0001127602-22-006343:0·
011,344 shares0
Common Stock
SEC:0001127602-22-002801·
011,344 shares0
Common Stock
SEC:0001127602-22-002801:0·
0182 shares0
Common Stock
SEC:0001127602-21-031913·
0182 shares0
Common Stock
SEC:0001127602-21-031913:0·
€493,8631,458 shares@ €338.72630.0068% mcap100.0% of flow
Common Stock
SEC:0001127602-21-023433·
€493,8631,458 shares@ €338.72630.0068% mcap45.3% of flow
Common Stock
SEC:0001127602-21-023433:0·
01,124 shares0
Common Stock
SEC:0001127602-21-018567·
01,124 shares0
Common Stock
SEC:0001127602-21-018567:0·
11 of 11 declarations
About LaPlume Joseph W
Joseph W. LaPlume is Executive Vice President, Corporate Strategy & Development at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. He is responsible for developing and implementing strategies aimed at fostering growth and innovation within the company.
